Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
Holding HCAT?
Track your performance easily
HCAT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.42 - $11.41
Previous Close$8.74
Volume346.10K
Average Volume (3M)533.79K
Market Cap
$528.51M
Enterprise Value$468.92M
Total Cash (Recent Filing)$308.26M
Total Debt (Recent Filing)$248.67M
Price to Earnings (P/E)―
Beta2.18
Next Earnings
Nov 12, 2024EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.50
Shares Outstanding60,470,248
10 Day Avg. Volume527,447
30 Day Avg. Volume533,786
Standard Deviation0.15
R-Squared0.22
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.48
Price to Sales (P/S)1.76
Price to Cash Flow (P/CF)81.60
P/FCF Ratio126.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.57
Enterprise Value/Gross Profit3.56
Enterprise Value/Ebitda-8.71
Forecast
1Y Price Target
$11.18Price Target Upside26.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Health Catalyst News
Bulls Say, Bears Say
Bulls Say
Growth OutlookManagement was incrementally more positive on the growth outlook, updating expectations for net new platform subscription client additions to the low-twenties from mid-teens.
Platform Quality And InterestThe company's introduction of its Ignite platform appears to be generating significant interest from existing and potential new customers.
Revenue GrowthImproved modularity and flexibility of the platform and improved cross-selling effectiveness to non-platform clients are driving added confidence in the outlook for a return to double-digit revenue growth in 2025.
Bears Say
CapabilitiesWhether HCAT has the arsenal of capabilities to drive cross-sell opportunities given a large legacy of all-in DOS clients and declining benefits of auto-escalators.
DebtConvertible debt maturing is making the market reluctant to bid on the stock given the uncertainty about HCAT's refinancing path.
GuidanceDollar based retention guidance was reduced to 100%-106% (from 104% to 110% prior).
---
Ownership Overview
21.10% Insiders
28.75% Mutual Funds
45.18% Other Institutional Investors
4.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $5.42 and its highest was $11.41 in the past 12 months.
What is Health Catalyst’s market cap?
Currently, no data Available
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Nov 12, 2024 which is in 53 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Aug 07, 2024. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.04.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is $0.1.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 60,470,250 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.12 in its last earnings report, beating expectations of $0.08. Following the earnings report the stock price went up 37.774%.
Which hedge fund is a major shareholder of Health Catalyst?
Among the largest hedge funds holding Health Catalyst’s share is PRIMECAP Management Co. It holds Health Catalyst’s shares valued at 15M.
---
Health Catalyst Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.18 (26.33% Upside)
$11.18 (26.33% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 292.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.9%
Last 30 Days ▼ 9.0%
Last 30 Days ▼ 9.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.28%
12-Months-Change
Fundamentals
Return on Equity
-23.15%
Trailing 12-Months
Asset Growth
-4.31%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
---
HCAT Earnings Call
Q2 2024
0:00 / 0:00
---
HCAT Stock 12 Month Forecast
Average Price Target
$11.18
▲(26.33% Upside)
Technical Analysis
Best Analysts Covering HCAT
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+8.81%
reiterated a buy rating last month
Copying Stan Berenshteyn's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +8.81% per trade.
---